“The application follows three consecutive years of improvement in its underlying operating performance, with underlying profit before tax increasing from about RMB2.7 million in FY2023 to RMB7.7 million in FY2024 and RMB8.4 million in FY2025,” Tang states.
UOB KayHian analyst Tang Kai Jie has maintained his “buy” recommendation on Aoxin Q&M (SGX:1D4
) following the recent announcement on its application to transfer its listing status from Catalist to Mainboard.
In his July 9 report, Tang mentioned that this marks an important milestone that reflects its stronger financial position and growing business maturity.
